【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
07.Global Active Pharmaceutical Ingredients Market
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08.Market Segmentation by Type of Production Process
08.1 Global Market for Synthetically Produced Active Pharmaceutical Ingredients
08.1.1 Market Size and Forecast
08.2 Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
08.2.1 Market Size and Forecast
08.2.2 Market Segmentation by Type of Product
09.Market Segmentation by Type of Product
09.1 Global High-potency Active Pharmaceutical Ingredients Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Type of Production Process
09.1.3 Market Segmentation by Type of Product
10.Market Segmentation by Type of Player
10.1 Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product
11.Geographical Segmentation
11.1 Active Pharmaceutical Ingredients Market in Americas
11.1.1 Market Size and Forecast
11.2 Active Pharmaceutical Ingredients Market in APAC Region
11.2.1 Market Size and Forecast
11.3 Active Pharmaceutical Ingredients Market in EMEA Region
11.3.1 Market Size and Forecast
12.Key Leading Countries
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.2 Key Vendors 2014
20.3 Other Prominent Vendors
20.3.1 Abbott Laboratories
20.3.2 Actavis
20.3.3 Aesica
20.3.4 Albemarle
20.3.5 AMPAC Fine Chemicals
20.3.6 Anhui Biochem United Pharmaceutical
20.3.7 Anuh Pharma
20.3.8 Aptuit
20.3.9 AstraZeneca
20.3.10 Biocon
20.3.11 Bristol-Myers Squibb
20.3.12 Calyx Chemicals & Pharmaceuticals
20.3.13 Cambrex
20.3.14 Cilag
20.3.15 CIRON Drugs and Pharmaceuticals
20.3.16 CTX Life Sciences
20.3.17 Dishman Pharmaceuticals & Chemicals
20.3.18 Dr. Paul Lohmann
20.3.19 Emcure Pharmaceuticals
20.3.20 Farmabios
20.3.21 F. Hoffmann-La Roche
20.3.22 GlaxoSmithKline
20.3.23 Guilin Pharmaceutical
20.3.24 Hetero Drugs
20.3.25 Hospira
20.3.26 Ipca Laboratories
20.3.27 Janssen Pharmaceutica
20.3.28 Johnson Matthey
20.3.29 Laurus Labs
20.3.30 Lupin
20.3.31 Mallinckrodt Pharmaceuticals
20.3.32 Mangalam Drugs & Organics
20.3.33 Merck
20.3.34 Mylan
20.3.35 Novartis
20.3.36 Novasep
20.3.37 Pen Tsao Chemical Industry
20.3.38 Pfizer
20.3.39 Ranbaxy Laboratories
20.3.40 Royal DSM
20.3.41 Sanofi-Aventis
20.3.42 Sequent Scientific
20.3.43 Shanghai Desano Chemical Pharmaceutical
20.3.44 Shasun
20.3.45 Shijiazhuang Lonzeal Pharmaceuticals
20.3.46 Sigma-Aldrich
20.3.47 ST Pharm
20.3.48 Sun Pharmaceutical Industries
20.3.49 WuXi AppTec
20.3.50 Zhejiang Langhua Pharmaceutical
20.3.51 Zhuhai Rundu Pharmaceutical
21.Key Vendor Analysis
21.1 Aurobindo Pharma
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Geographical Segmentation by Revenue 2014
21.1.5 Business Strategy
21.1.6 Recent Developments
21.1.7 SWOT Analysis
21.2 BASF
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business/Product Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Boehringer Ingelheim
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Cipla
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Geographical Segmentation by Revenue 2014
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Dr. Reddy’s Laboratories
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
21.6 Lonza Group
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
21.7 Teva Pharmaceutical Industries
21.7.1 Key Facts
21.7.2 Business Overview
21.7.3 Business Segmentation
21.7.4 Business Segmentation by Revenue 2013
21.7.5 Business Segmentation by Revenue 2012 and 2013
21.7.6 Sales by Geography
21.7.7 Business Strategy
21.7.8 Key Developments
21.7.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
Exhibit 29: WHO’s List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
Exhibit 30: Aurobindo Pharma: Business Segmentation
Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 32: BASF: Business Segmentation 2013
Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 38: Cipla: Product Segmentation
Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 42: Dr. Reddy’s Laboratories: Geographical Segmentation by Revenue 2014
Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013
【レポート販売概要】
■ タイトル：医薬品有効成分（原薬/API）の世界市場■ 英文：Global Active Pharmaceutical Ingredients Market 2015-2019
■ 発行日：2014年12月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4885
■ 調査対象地域：グローバル
- 産業用ローブポンプの世界市場2016-2020About the Industrial Lobe Pump Market Lobe pumps are categorized as positive displacement pumps, which are used mainly in industrial applications that involve the pumping and lifting of heavy fluids like sludge, slurry, and mud. Sludge is a semi-solid slurry that is primarily a by-product of sewage from wastewater treatment or may be in the form of a settled suspension from numerous industrial pro …
- 水添レシチンの世界市場2015Lecithin, hydrogenated (CAS 92128-87-5) Market Research Report 2015 aims at providing comprehensive data on Lecithin, hydrogenated market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Lecithin, hydrogenated description, covers its application areas, manufacturing methods, patterns. It captures Lecithin, hydrogenated market trends, pays close attentio …
- 植物成長調整剤（PGR）の世界市場：オーキシン、サイトカイニン、ジベレリンThe plant growth regulators market is projected to grow at a CAGR of 3.6% from 2015 to reach a projected value of USD 1.91 Billion by 2020. The market growth is driven by growing customer attention towards enhancing the premium value of fruits, vegetables, ornamentals and other permanent crops. The market is further driven by factors such as technology and product development of innovative plant g …
- 超音波診断装置の世界市場2019-2023About this market The reliability of power generation equipment is essential as the failure of systems might adversely affect the Mole power network infrastructure and pose serious safety risks. Ultrasonic testing is used for inspecting power generation infrastructures such as boilers, turbines, compressors: pipelines, tanks, and storage vessels. Power demand has been growing globally, both as a r …
- 赤痢菌感染症(赤痢)(Shigella Infections (Shigellosis))：治療薬開発パイプライン動向（2015年上半期版）Shigella Infections (Shigellosis) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H1 2015’, provides an overview of the Shigella Infections (Shigellosis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Shigella Infections (Shigellosis), complete with comparative analysis at v …
- 世界のぎ酸市場2015The Global Formic Acid Industry Report 2015 is a professional and in-depth study on the current state of the Formic Acid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Formic Acid market analysis is provided for the international markets including development trends, competitive landscape analysis …
- PLCスプリッターのグローバル市場2014This is the ElectroniCast analysis and forecast of global market consumption of planar lightwave circuit (PLC) splitters used in optical communication applications. For the purposes of this study, ElectroniCast specifically addresses the PLC splitter, using waveguide circuits and aligned fiber optic pigtails, integrated inside a package. This report also quantifies the PLC splitter chip used in PL …
- Dementia：グローバル臨床試験レビューH2, 2013Dementia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, H2, 2013" provides data on the Dementia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ボックスオフィス（興業収益）の世界市場2016-2020About the Box Office Market In 2010-2015, the international box office revenue increased by 33%. The main reason for the growing success of the film industry is the increasing synchronization between the film makers and distributors regarding the screening of a movie in multiplexes. The movie screens also develop in quality as the 3D effects used in the films improves. Despite technological advanc …
- 機内エンターテイメントシステムの世界市場2015-2019About In-flight IFE systems are integral value additions for airlines, primarily on long routes. While IFE systems have been around for some time, the move toward providing in-flight connectivity is relatively new. These services enable passengers to enjoy their in-flight time through a host of programs such as games and movies, and enable airlines to effectively engage their passengers and gain a …
- フローサイトメトリーの世界市場2015：市場機会、参入戦略This report identifies major opportunities emerging in the flow cytometry market for new instruments, consumables, and auxiliary products; proposes ?ideal? product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers.Contains 8 pages
- 2014年戦略提言：Papillomavirusの診断検査市場The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals &n …
- サードパーティ・バンキング・ソフトウェアの世界市場About Third-party Banking Software A third-party software vendor, unlike the legacy system that is developed by a bank’s own in-house IT staff, develops third-party banking software. Worldwide banks are increasingly becoming dissatisfied with legacy systems. These systems lack innovative functionalities available in the modern systems today. Integration of new functionalities in a legacy system is …
- 血栓除去術用装置の世界市場予測（～2022年）The global thrombectomy devices market is expected to reach a value of USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. A number of factors such as growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging …
- 蚊よけ剤（虫よけ剤）の世界市場2015-2019About mosquito repellent Mosquito repellents, used to prevent mosquito bites, are available in the market as coils, vaporizers, sprays, mats, creams, and bands. According to WHO, rising global warming is an important factor leading to increase in the number of mosquitoes that carry diseases like malaria, yellow fever, and dengue. With more people taking preventive measures against mosquito-borne d …
